Additionally, among patients with tumor sizes <4.0 cm, 15 out of 48 (15/48, 31.3%) exhibited positive AGR2 expression, compared to 24 out of 58 (24/58, 41.4%) in those with tumors measuring 4.0 cm or greater. The gene discussed is AGR2; the disease is neoplasm.